SPS - Specialist Pharmacy Service

The first stop for professional medicines advice

About
Contact
Log in
Register

NHS

COVID-19 Vaccines
COVID-19 Vaccines

COVID-19 Vaccines index

General information and guidance

Pfizer-BioNTech

AstraZeneca

Moderna

Search COVID-19 Vaccines
Vaccines content by guidance area

Administering

Adverse effects

Anaphylaxis

Cautions and contraindications

Cold chain management

Disposal

Dosing

Excipients

Immunosuppressives

Interactions

Porphyria

Preparing

Regulatory

Safety in Breastfeeding

Safety in Pregnancy

Service advice

Supply

Testing and diagnosis
Vaccines content by clinical speciality

Allergy and immunology

Cancers

Cardiovascular system disorders

Haematological disorders

Infection and infectious diseases

Musculo-skeletal disorders

Surgery
Guidance
Guidance

Guidance index

COVID-19 Treatments

COVID-19 Medicines Optimisation

PGDs

Administering

Cautions and contraindications

Dosing

Monitoring

Switching

Interactions

Supply

Polypharmacy

Best practice sharing

Safety in breastfeeding

Safety in pregnancy

Stability outside the fridge

Excipients

Stability in dosette boxes

Swallowing difficulties

Stability of cytotoxics

Aseptic services

Manufacturing and preparation

Unlicensed medicines

Homecare

ATMPs

Medical gases

Search Guidance
Guidance by Care Setting

Care homes

Care of the elderly

Community Health Services

Critical care

Dentistry

Emergency medicine and urgent care

Health and Justice

Occupational Health

Paediatrics and neonates

Palliative and End of Life Care

Primary Care

Transfer of care

Trusts
Guidance by Specialty

Allergy and immunology

Anaesthesia and pain

Cancers

Cardiovascular system disorders

Diabetes

Ear, nose and throat disorders

Endocrine system disorders

Eyes and vision

Family planning

Gastrointestinal disorders

Haematological disorders

Infection and infectious diseases

Learning disabilities

Liver disorders

Mental health and illness

Musculo-skeletal disorders

Neurological disorders

Nutritional and metabolic disorders

Obstetrics and gynaecology

Renal and urologic disorders

Respiratory disorders

Sexual health

Skin disorders

Surgery

Travel Medicine

Vaccinating

Wounds and injuries
Events
Events

Events index

Webinars

Conferences

Search Events
Events by Care Setting

Care homes

Care of the elderly

Community Health Services

Health and Justice

Palliative and End of Life Care

Primary Care
Events by Specialty

Cardiovascular system disorders

Haematological disorders

Infection and infectious diseases

Mental health and illness

Respiratory disorders
Networks
Networks

Networks index

Regional Medicines Optimisation Committees

Antimicrobial resistance networks

Pan-UK Pharmacy Working Group for ATMPs

UK Medicines Information

Search Networks
Planning
Planning

Planning index

New Medicines

Biosimilars

Patent expiries

Search Planning
Planning by Care Setting

Community Health Services

Dentistry

Emergency medicine and urgent care

Health and Justice

Paediatrics and neonates

Primary Care

Transfer of care

Trusts
Planning by Specialty

Allergy and immunology

Anaesthesia and pain

Cancers

Cardiovascular system disorders

Diabetes

Ear, nose and throat disorders

Endocrine system disorders

Eyes and vision

Family planning

Gastrointestinal disorders

Haematological disorders

Infection and infectious diseases

Liver disorders

Mental health and illness

Musculo-skeletal disorders

Neurological disorders

Nutritional and metabolic disorders

Obstetrics and gynaecology

Renal and urologic disorders

Respiratory disorders

Sexual health

Skin disorders

Stroke

Surgery

Vaccinating

Wounds and injuries
Training
Training

Training index

Courses

Materials

Search Training
Training by Care Setting

Community Health Services

Primary Care

Transfer of care

Trusts
Training by Specialty

Mental health and illness
Publications
Publications

Publications index

Standard Operating Procedures

RMOC Recommendations and Resources

Newsletters

Bulletins and summaries

Research and audits

Search Publications
Publications by Care Setting

Care homes

Care of the elderly

Community Health Services

Emergency medicine and urgent care

Health and Justice

Paediatrics and neonates

Palliative and End of Life Care

Primary Care

Transfer of care

Trusts
Publications by Specialty

Anaesthesia and pain

Cancers

Cardiovascular system disorders

Diabetes

Ear, nose and throat disorders

Endocrine system disorders

Eyes and vision

Family planning

Gastrointestinal disorders

Haematological disorders

Infection and infectious diseases

Learning disabilities

Liver disorders

Mental health and illness

Musculo-skeletal disorders

Neurological disorders

Nutritional and metabolic disorders

Obstetrics and gynaecology

Renal and urologic disorders

Respiratory disorders

Sexual health

Skin disorders

Vaccinating

Wounds and injuries
Search

New Medicines
Biosimilars
Patent expiries
More
Less

Home
Planning
Patent expiries

Bazedoxifene + conjugated estrogens

Published 25 November 2015

Topics: Endocrine system disorders · Patent expiries

Contents

dm+d

dm+d

Unassigned

Related

Empagliflozin

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Pre-registration new medicines (UK/EU) · 11 February 2016

Lanreotide

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability outside the fridge · 3 February 2016

Ospemifene

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

CCG commissioned new medicines · 3 February 2016

Thyrotropin alfa

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Thyrotropin alfa · 12 October 2015

Repaglinide

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability in dosette boxes · 17 April 2015

Ibandronic acid

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability in dosette boxes · 17 April 2015

Sitagliptin

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability in dosette boxes · 17 April 2015

Corifollitropin alfa

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

CCG commissioned new medicines · 17 April 2015

Sitagliptin + Metformin

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability in dosette boxes · 17 April 2015

Raloxifene

A combination of the third generation selective estrogen receptor modulator (SERM), bazedoxifene, and the conjugated estrogen, Premarin

Stability in dosette boxes · 17 April 2015

Feedback

SPS support and the COVID-19 Vaccination Programme

We're supporting healthcare professionals with the COVID-19 Vaccination Programme in England. Read more about how we're helping below.

Our remit for the programme
Advice for patients
Answering your questions and getting in touch
Staying up-to-date

Didn’t find what you were looking for?

If you need to know more and you're a healthcare professional in England, you can ask one of our experts for help.

Ask a question

SPS – Specialist Pharmacy Service - The first stop for professional medicines advice

Accessibility · Terms and Conditions · Copyright © 2021 SPS - Specialist Pharmacy Service. All Rights Reserved.